This report highlights the case of a patient with falsely elevated TG levels (pseudo-HTG) caused by glycerol kinase deficiency (GKD) who appeared not to benefit from TG-lowering treatment with plozasiran, an APOC3 siRNA. Here, GK is linked to inborn glycerol kinase deficiency.